Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study

Guardat en:
Dades bibliogràfiques
Publicat a:Haematologica
Autors principals: Salles, Gilles, Schuster, Stephen J., de Vos, Sven, Wagner-Johnston, Nina D., Viardot, Andreas, Blum, Kristie A., Flowers, Christopher R., Jurczak, Wojciech J., Flinn, Ian W., Kahl, Brad S., Martin, Peter, Kim, Yeonhee, Shreay, Sanatan, Will, Matthias, Sorensen, Bess, Breuleux, Madlaina, Zinzani, Pier Luigi, Gopal, Ajay K.
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2017
Matèries:
Online Only Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5395130/
https://ncbi.nlm.nih.gov/pubmed/27979923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2016.151738
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars